Cancer drug trial halted early: what we know

NCT ID NCT02712905

Terminated Disease control Sponsor: Incyte Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new drug called INCB059872 in people with advanced solid tumors or blood cancers that had not responded to standard treatments. The goal was to find a safe dose and see if it could control the disease. The trial was stopped early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EWING SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia Ewing sarcoma hematopoietic and lymphoid system neoplasm myelodysplastic syndrome Myelodysplastic Syndromes myelofibrosis neuroendocrine carcinoma primary myelofibrosis small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMORS AND HEMATOLOGIC MALIGNANCY

Contacts and locations

Locations

Columbia University

New York, New York, 10027, United States
Erasmus MC

Rotterdam, Netherlands
Institut Jules Bordet

Brussels, Belgium
Moores UCSD Cancer Center

La Jolla, California, 92093, United States
Netherland Cancer Institute

Amsterdam, Netherlands
Northwestern University

Chicago, Illinois, 60208, United States
Oregon Health Science University

Portland, Oregon, 97297, United States
Roswell Park Cancer Institute

Buffalo, New York, 14263, United States
UCLA Medical Center

Los Angeles, California, 90095, United States
University of Alabama

Birmingham, Alabama, 35487, United States
University of Kansas Center for Research, Inc.

Kansas City, Kansas, 66045, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States
VU Medical Center

Amsterdam, Netherlands
Vanderbilt University

Nashville, Tennessee, 37240, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.